A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
Clinical trial NCT05234437 · TERMINATED
Trial details
- NCT number
- NCT05234437
- Sponsor
- QBiotics Group Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2022-07-18
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.